Orchestra BioMed Holdings (OBIO) Income towards Parent Company (2022 - 2025)
Historic Income towards Parent Company for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$20.8 million.
- Orchestra BioMed Holdings' Income towards Parent Company fell 3501.88% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 3371.97%. This contributed to the annual value of -$60.9 million for FY2024, which is 2788.26% down from last year.
- According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Income towards Parent Company is -$20.8 million, which was down 3501.88% from -$19.4 million recorded in Q2 2025.
- Over the past 5 years, Orchestra BioMed Holdings' Income towards Parent Company peaked at -$5.1 million during Q1 2022, and registered a low of -$20.8 million during Q3 2025.
- Moreover, its 4-year median value for Income towards Parent Company was -$13.4 million (2024), whereas its average is -$13.5 million.
- As far as peak fluctuations go, Orchestra BioMed Holdings' Income towards Parent Company crashed by 12513.65% in 2023, and later tumbled by 1335.15% in 2024.
- Over the past 4 years, Orchestra BioMed Holdings' Income towards Parent Company (Quarter) stood at -$9.8 million in 2022, then decreased by 15.72% to -$11.4 million in 2023, then plummeted by 42.05% to -$16.2 million in 2024, then decreased by 28.93% to -$20.8 million in 2025.
- Its last three reported values are -$20.8 million in Q3 2025, -$19.4 million for Q2 2025, and -$18.8 million during Q1 2025.